Research ArticleBRAIN
MR Imaging and Single-Photon Emission CT Findings after Gene Therapy for Human Glioblastoma
Frank W. Floeth, Albrecht Aulich, Karl J. Langen, Klaus J. Burger, Wolfgang J. Bock and Friedrich Weber
American Journal of Neuroradiology September 2001, 22 (8) 1517-1527;
Frank W. Floeth
Albrecht Aulich
Karl J. Langen
Klaus J. Burger
Wolfgang J. Bock

References
- ↵Davis FG, Malinski N, Haenszel W, et al. Primary brain tumor incidence rates in four United States regions, 1985–1989: a pilot study. Neuroepidemiology 1996;15:103-112
- ↵Devaux BC, O'Fallon JR, Kelly PJ. Resection, biopsy and survival in malignant glial neoplasms. J Neurosurg 1993;78:767-775
- ↵Sheline GE. Radiotherapy for high-grade gliomas. Int J Radiat Oncol Biol Phys 1990;18:793-803
- ↵Kiwit JCW, Floeth FW, Bock WJ. Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Zentralbl Neurochir 1996;57:76-88
- ↵Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994;34:45-61
- ↵Rajan B, Ross G, Lim CC, et al. Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy. Eur J Cancer 1994;30A:1809-1815
- ↵
- Shand N, Weber F, Mariani L, et al. A Phase 1–2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. Hum Gene Ther 1999;10:2325-2335
- ↵Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986;6:2895-2902
- ↵Langen K-J, Ziemons K, Kiwit JCW, et al. [123I]Iodo-α-methyltyrosine SPECT and [11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med 1997;38:517-522
- ↵Henegar MM, Moran CJ, Silbergeld DL. Early postoperative magnetic resonance imaging following nonneoplastic cortical resection. J Neurosurg 1996;84:174-179
- ↵Smith MM, Thompson JE, Castillo M, et al. MR of recurrent high-grade astrocytomas after intralesional immunotherapy. AJNR Am J Neuroradiol 1996;17:1065-1071
- ↵Deliganis AV, Baxter AB, Berger MS, Marcus SG, Maravilla KR. Serial MR in gene therapy for recurrent glioblastoma: initial experience and work in progress. AJNR Am J Neuroradiol 1997;18:1401-1406
- ↵Ram Z, Culver KW, Oshiro EM, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nature Med 1997;3:1354-1361
- Ramesh R, Marrogi AJ, Freeman SM. Tumor killing using the HSV-tk suicide gene. Gene Ther Mol Biol 1998;1:253-263
- ↵Zimmerman RA. Imaging of adult central nervous system primary malignant gliomas. Staging and follow up. Cancer 1991;67:1278-1283
- Barker FG II, Chang SM, Valk PE, et al. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer 1997;79:115-126
- Fulham MJ, Di Chiro G. Neurologic PET and SPECT. In: Harbert T, Eckelman W, Neumann R, eds. Textbook of Nuclear Medicine. Basel: Thieme; 1996;361–385
- Davis WK, Boyko OB, Hoffman JM, et al. [18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. AJNR Am J Neuroradiol 1993;14:515-523
- Herholz K, Pietrzyk U, Voges J, et al. Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. J Neurosurg 1993;79:853-858
- ↵Schifter T, Hoffman JM, Hanson MW, et al. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comput Assist Tomogr 1993;17:509-516
- ↵
- Kaibara T, Tyson RL, Sutherland GR. Human cerebral neoplasms studied using MR spectroscopy: a review. Biochem Cell Biol 1998;76:477-486
- Preul MC, Leblanc R, Caramanos Z, et al. Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases. Can J Neurol Sci 1998;25:13-22
- Tedeschi G, Lundbom N, Raman R, et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997;87:516-524
- Kinoshita Y, Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 1997;10:2-12
- Shimizu H, Kumabe T, Tominaga T, et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:737-747
- Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Med 1996;2:323-325
- Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449-458
- Poptani H, Gupta RK, Roy R, et al. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 1995;16:1593-1603
- Michaelis T, Merboldt KD, Bruhn H, et al. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187:219-227
- ↵Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686
- ↵Langen K-J, Coenen HH, Roosen N, et al. SPECT studies of brain tumors with L-3-[123I]Iodo-α-methyl tyrosine: comparison with PET, 124IMT and first clinical results. J Nucl Med 1990;31:281-286
- ↵
- ↵
In this issue
Advertisement
MR Imaging and Single-Photon Emission CT Findings after Gene Therapy for Human Glioblastoma
Frank W. Floeth, Albrecht Aulich, Karl J. Langen, Klaus J. Burger, Wolfgang J. Bock, Friedrich Weber
American Journal of Neuroradiology Sep 2001, 22 (8) 1517-1527;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent Glioblastoma
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria
- Comparison of O-(2-18F-Fluoroethyl)-L-Tyrosine PET and 3-123I-Iodo-{alpha}-Methyl-L-Tyrosine SPECT in Brain Tumors
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement